Edwards Lifesciences (EW) Common Equity (2009 - 2026)
Edwards Lifesciences' quarterly Common Equity came in at $10.3 billion in Q1 2026, up 1.33% year-on-year from $10.2 billion in Q1 2025, and little changed quarter-over-quarter from $10.3 billion in Q4 2025.
Edwards Lifesciences has reported Common Equity for 18 years, with the latest figure at $10.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Common Equity rose 1.33% year-over-year to $10.3 billion; the trailing twelve-month figure through Mar 2026 stood at $10.3 billion (up 1.33% YoY), and the FY2025 full-year result was $10.3 billion, up 2.73% from the prior year.
- Common Equity for Q1 2026 stood at $10.3 billion, roughly flat from $10.3 billion in the prior quarter.
- The five-year high for Common Equity was $10.6 billion in Q2 2025, with the low at $5.8 billion in Q4 2022.
- Average Common Equity over 5 years is $8.0 billion, with a median of $7.2 billion recorded in 2024.
- Year-over-year, Common Equity declined 0.5% in 2022 and surged 49.76% in 2024.
- Tracing EW's Common Equity over 5 years: stood at $5.8 billion in 2022, then grew by 15.72% to $6.7 billion in 2023, then jumped by 49.76% to $10.1 billion in 2024, then increased by 2.73% to $10.3 billion in 2025, then dropped by 0.1% to $10.3 billion in 2026.
- The last three Common Equity figures came in at $10.3 billion (Q1 2026), $10.3 billion (Q4 2025), and $10.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 12.67 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.33 Bn |
| Dec 31, 2025 | 10.34 Bn |
| Sep 30, 2025 | 10.21 Bn |
| Jun 30, 2025 | 10.61 Bn |
| Mar 31, 2025 | 10.19 Bn |
| Dec 31, 2024 | 10.06 Bn |
| Sep 30, 2024 | 9.61 Bn |
| Jun 30, 2024 | 7.50 Bn |
| Mar 31, 2024 | 7.19 Bn |
| Dec 31, 2023 | 6.72 Bn |
| Sep 30, 2023 | 6.73 Bn |
| Jun 30, 2023 | 6.45 Bn |
| Mar 31, 2023 | 6.06 Bn |
| Dec 31, 2022 | 5.81 Bn |
| Sep 30, 2022 | 6.22 Bn |
| Jun 30, 2022 | 5.94 Bn |
| Mar 31, 2022 | 5.84 Bn |
| Dec 31, 2021 | 5.84 Bn |
| Sep 30, 2021 | 5.54 Bn |
| Jun 30, 2021 | 5.13 Bn |
| Mar 31, 2021 | 4.66 Bn |
| Dec 31, 2020 | 4.57 Bn |
| Sep 30, 2020 | 4.21 Bn |
| Jun 30, 2020 | 3.84 Bn |
| Mar 31, 2020 | 3.90 Bn |
| Dec 31, 2019 | 4.15 Bn |
| Sep 30, 2019 | 3.81 Bn |
| Jun 30, 2019 | 3.50 Bn |
| Mar 31, 2019 | 3.45 Bn |
| Dec 31, 2018 | 3.14 Bn |
| Sep 30, 2018 | 3.36 Bn |
| Jun 30, 2018 | 3.16 Bn |
| Mar 31, 2018 | 3.25 Bn |
| Dec 31, 2017 | 2.96 Bn |
| Sep 30, 2017 | 3.16 Bn |
| Jun 30, 2017 | 2.94 Bn |
| Mar 31, 2017 | 2.74 Bn |
| Dec 31, 2016 | 2.62 Bn |
| Sep 30, 2016 | 2.69 Bn |
| Jun 30, 2016 | 2.47 Bn |
| Mar 31, 2016 | 2.30 Bn |
| Dec 31, 2015 | 2.50 Bn |
| Sep 30, 2015 | 2.42 Bn |
| Jun 30, 2015 | 2.29 Bn |
| Mar 31, 2015 | 2.21 Bn |
| Dec 31, 2014 | 2.19 Bn |
| Sep 30, 2014 | 2.04 Bn |
| Jun 30, 2014 | 1.91 Bn |
| Mar 31, 2014 | 1.34 Bn |
| Dec 31, 2013 | 1.54 Bn |
| Sep 30, 2013 | 1.44 Bn |
| Jun 30, 2013 | 1.58 Bn |
| Mar 31, 2013 | 1.59 Bn |
| Dec 31, 2012 | 1.47 Bn |
| Sep 30, 2012 | 1.54 Bn |
| Jun 30, 2012 | 1.43 Bn |
| Mar 31, 2012 | 1.39 Bn |
| Dec 31, 2011 | 1.33 Bn |
| Sep 30, 2011 | 1.35 Bn |
| Jun 30, 2011 | 1.39 Bn |
| Mar 31, 2011 | 1.36 Bn |
| Dec 31, 2010 | 1.31 Bn |
| Sep 30, 2010 | 1.23 Bn |
| Jun 30, 2010 | 1.12 Bn |
| Dec 31, 2009 | 1.16 Bn |